{
    "2018-10-11": [
        [
            {
                "time": "",
                "original_text": "沃森生物：前三季度预计扭亏为盈 净利9000万元—9500万元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "扭亏为盈",
                        "净利",
                        "9000万元—9500万元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：2018年前三季度业绩报告预告",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2018年",
                        "前三季度",
                        "业绩报告",
                        "预告"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[快讯]沃森生物公布第三季度业绩预告",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "第三季度",
                        "业绩预告"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：前三季度预计扭亏 自主疫苗产品净利润增长2.66倍",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "扭亏",
                        "自主疫苗",
                        "净利润增长",
                        "2.66倍"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}